A Clear Voice

S2 Ep 5: Prof Martin Birchall returns to discuss Laryngological aspects of COVID-19 six months on

December 11, 2020 BLA Connections Season 2 Episode 5
A Clear Voice
S2 Ep 5: Prof Martin Birchall returns to discuss Laryngological aspects of COVID-19 six months on
Show Notes Chapter Markers

In episode 5 of 'A Clear Voice,'  we welcome back Prof Martin Birchall as he reflects, comments and shares his insights of COVID-19 six months on, the impact on individuals and laryngology as a whole as well as the future of laryngology post-COVID using new technologies.

In this episode:

1:43 Q1. Reflecting back on our previous episode, is there anything you would like to expand, comment or reflect on?

3:04 Q2.  How have things changed at UCLH for you? 

5:38 Q3. There are a couple of areas ENT focussed on, such as cancer and emergency operations, would you like to say a little about that? 

7:10 Q4. How do you think the COVID pandemic will impact on laryngology and the patients we treat?

12:29 Q5. How do you think that new technologies are shaping the future of laryngology post-COVID?

17:53 Take home message.

Guest Bio:  Prof. Martin Birchall 

Prof Birchall is one of the leading academic Otolaryngologists in the world, one of the leading academic surgeons in Europe and an international figure in the field of translational regenerative medicine. His work is dedicated to the successful translation of innovative technologies, especially in the field of stem cells and regenerative medicine, with a focus on alleviating suffering and improving the quality of life for those with disorders of the head and neck, voice and swallowing. He aims to achieve these goals through forming partnerships with the very best scientists and surgeons in the appropriate fields. These multidisciplinary teams focus on clear therapeutic targets.

He has supervised 9 PhD and 5 MD students, raised over £4 million in peer-reviewed grant money, including from MRC, NIH and the Wellcome Trust (nearly £2 million held presently) and has published 130 peer-reviewed scientific papers plus numerous reviews and reports. He is Director of UCL Partners ENT Programme and was named Morgan Stanley Briton of the Year in 2008.

He is also a founding member of the BLA and immediate past president.

Contact Information
Visit www.britishlaryngological.org or download BLA Connect from your app store for further information and details on becoming a BLA member.

Email: [email protected] for any questions or topic suggestions you may have for future episodes.

This show is brought to you by the BLA, you can follow us on  Twitter, Facebook, Linkedin and Instagram hosted by Natalie Watson @surgeonsinger produced and directed by Heather Pownall of Heather's Media Hub Ltd 

Q1. Reflecting back on our previous episode, is there anything you would like to expand, comment or reflect on?
Q2. How have things changed at UCLH for you?
Q3. There are a couple of areas ENT focussed on, such as cancer and emergency operations, would you like to say a little about that?
Q4. How do you think the COVID pandemic will impact on laryngology and the patients we treat?
Q5. How do you think that new technologies are shaping the future of laryngology post-COVID?
Take Home Message